Displaying drugs 6401 - 6425 of 6495 in total
Naporafenib
Naporafenib is under investigation in clinical trial NCT06346067 (A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With Nras-mutant Melanoma (SEACRAFT-2)).
Investigational
beta-Sitosterol
Active fraction of Solanum trilobatum; reduces side-effects of radiation-induced toxicity.
Experimental
Tositumomab I-131
Investigational
Fidrisertib
Investigational
Supinoxin
Supinoxin is under investigation in clinical trial NCT02003092 (RX-5902 Treatment of Subjects With Triple Negative Breast Cancer).
Investigational
Displaying drugs 6401 - 6425 of 6495 in total